Timeline wins $5.3m in fake urolithin A case

Federal court ruling highlights growing pressure for quality assurance as longevity interventions move into increasingly crowded market. Swiss longevity company Timeline has secured a permanent injunction and more than $5.3 million in damages against 19 online sellers found to have marketed supplements falsely advertised as containing urolithin A, following a default judgment issued by the […] The post Timeline wins $5.3m in fake urolithin A case appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.